Literature DB >> 32570986

Epithelial-Mesenchymal Transition in Endometriosis-When Does It Happen?

Lutz Konrad1, Raimund Dietze2, Muhammad A Riaz1, Georgios Scheiner-Bobis3, Judith Behnke4, Fabian Horné1, Alena Hoerscher1, Christoph Reising1, Ivo Meinhold-Heerlein1.   

Abstract

Epithelial-mesenchymal transition (EMT) is an important process of cell remodeling characterized by the gradual loss of the epithelial phenotype and progressive gain of a mesenchymal phenotype. EMT is not an all-or-nothing process, but instead a transition of epithelial to mesenchymal cells with intermediate cell states. Recently, EMT was described in endometriosis, and many EMT-specific pathways like Twist, Snail, Slug, Zinc finger E-box-binding homeobox 1/2 (ZEB1/2), E/N-cadherin, keratins, and claudins are involved. However, as pointed out in this review, a comparison of the eutopic endometrium of women with and without endometriosis yielded only subtle changes of these EMT markers. Furthermore, only very few alterations in cell-cell contacts could be found but without changes in the epithelial phenotype. This suggests only a partial EMT which is not a prerequisite for the detachment of endometrial cells and, thus, not critical for the first step(s) in the pathogenesis of endometriosis. In contrast, the majority of changes in the EMT-related marker expression were found in the ectopic endometrium, especially in the three endometriotic entities, ovarian, peritoneal, and deep infiltrating endometriosis (DIE), compared with the eutopic endometrium. In this review, we examine the most important EMT pathways described in endometriosis and propose that partial EMT might result from the interaction of endometrial implants with their surrounding microenvironment.

Entities:  

Keywords:  cell–cell contacts; endometriosis; endometrium; epithelial–mesenchymal transition; pathogenesis

Year:  2020        PMID: 32570986     DOI: 10.3390/jcm9061915

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  12 in total

Review 1.  Long non-coding RNAs in endometrial physiology and pathophysiology.

Authors:  Fatimah Aljubran; Warren B Nothnick
Journal:  Mol Cell Endocrinol       Date:  2021-02-04       Impact factor: 4.102

2.  Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis.

Authors:  Jane B Maoga; Muhammad A Riaz; Agnes N Mwaura; Georgios Scheiner-Bobis; Ezekiel Mecha; Charles O A Omwandho; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 3.  The Importance of Stromal Endometriosis in Thoracic Endometriosis.

Authors:  Ezekiel Mecha; Roselydiah Makunja; Jane B Maoga; Agnes N Mwaura; Muhammad A Riaz; Charles O A Omwandho; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Cells       Date:  2021-01-18       Impact factor: 6.600

4.  Knockdown hsa_circ_0063526 inhibits endometriosis progression via regulating the miR-141-5p / EMT axis and downregulating estrogen receptors.

Authors:  Zhangming Wei; Yi Hu; Xiang He; Mengmeng Zhang; Xinyue Zhang; Yali Wang; Xiaoling Fang; Liping Li
Journal:  Aging (Albany NY)       Date:  2021-12-30       Impact factor: 5.682

5.  WEE1 promotes endometriosis via the Wnt/β-catenin signaling pathway.

Authors:  Liya Shi; Xue Xue; Hui Tian; Hongjuan Ye; Hui Wang; Rongxiang Wang; Yu Liu; Caixia Zhang; Qiuju Chen; Lihua Sun
Journal:  Reprod Biol Endocrinol       Date:  2021-10-22       Impact factor: 5.211

Review 6.  MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology.

Authors:  Warren B Nothnick
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

7.  Di-(2-ethylhexyl) Phthalate Triggers Proliferation, Migration, Stemness, and Epithelial-Mesenchymal Transition in Human Endometrial and Endometriotic Epithelial Cells via the Transforming Growth Factor-β/Smad Signaling Pathway.

Authors:  Hwi Gon Kim; Ye Seon Lim; Seonyeong Hwang; Hye-Yoon Kim; Yuseok Moon; Yong Jung Song; Yong-Jin Na; Sik Yoon
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

8.  Modified Sijunzi Decoction Inhibits Epithelial-Mesenchymal Transition of Non-Small Cell Lung Cancer by Attenuating AKT/GSK3β Pathway in vitro and in vivo.

Authors:  Niu Shao; Yao Xiao; Jiaxin Zhang; Yuying Zhu; Shenglong Wang; Suzhen Bao
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

9.  Urolithin A Inhibits Epithelial-Mesenchymal Transition in Lung Cancer Cells via P53-Mdm2-Snail Pathway.

Authors:  Feng Cheng; Jintao Dou; Yong Zhang; Xiang Wang; Huijun Wei; Zhijian Zhang; Yuxiang Cao; Zhihao Wu
Journal:  Onco Targets Ther       Date:  2021-05-17       Impact factor: 4.147

10.  Combination of Ferulic Acid, Ligustrazine and Tetrahydropalmatine attenuates Epithelial-mesenchymal Transformation via Wnt/β-catenin Pathway in Endometriosis.

Authors:  Chengling Zhang; Ying Zhang; Haiying Pan; Yi Tan; Qinghua Wei; Xueshan Dai; Jiahui Wei; Yi Chen
Journal:  Int J Biol Sci       Date:  2021-06-11       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.